HMC Launches Pioneering Brain Imaging Service For Early Detection Of Alzheimer's Disease

(MENAFN- Gulf Times) Hamad Medical Corporation (HMC) has announced the launch of an advanced amyloid brain PET-CT imaging service, the first of its kind in the country, delivered through the nuclear medicine and molecular imaging section of the Clinical Imaging Department step represents a significant advancement in the early diagnosis of neurodegenerative diseases. Amyloid imaging using PET enables the non-invasive detection of beta-amyloid deposits in the brain, which are key pathological markers of Alzheimer's disease. This technology helps differentiate Alzheimer's from other forms of dementia and supports precise treatment decisions, particularly in complex or diagnostically uncertain cases introduction of this service is the result of a multidisciplinary collaboration between the nuclear medicine and molecular imaging section of the Clinical Imaging Department and the Geriatric Memory Clinic at Rumailah Hospital, ensuring a comprehensive, patient-centered approach that enhances the quality of care this service, HMC reaffirms its commitment to innovation and precision medicine, as well as to expanding specialized services in line with the highest standards of quality and safety. This further strengthens its position as a leader in advanced diagnostic imaging and supports Qatar's healthcare priorities toward early detection and improved patient outcomes.

Alzheimer HMC Qatar

MENAFN02052026000067011011ID1111062098